DANIEL T. K. HURLEY, District Judge.
This Complaint involves two years, three laboratories, 132 substance abuse patients, and $2,000,000 in unpaid claims. On average, the laboratories claim at least $15,000 for services provided to each patient. The services were urine tests, and the insurance companies have refused to pay.
Federal Rule of Civil Procedure 8(a)(2) requires a complaint to contain "a short and plain statement of the claim showing that the pleader is entitled to relief." Under Rule 12(b)(6), a defendant may move to dismiss a complaint for "failure to state a claim upon which relief can be granted." To withstand a motion to dismiss, "a complaint must contain sufficient factual matter, accepted as true, to `state a claim to relief that is plausible on its face.'" Ashcroft v. Iqbal, 556 U.S. 662, 678 (2009) (quoting Bell Atlantic Corp. v. Twombly, 550 U.S. 544, 570 (2007)).
Plaintiffs are Peacock Medical Lab, LLC; PBL Medical, LLC; and Lake Drive Medical, LLC, collectively "the Laboratories." 1st Am. Comp. ¶¶ 11-14. Each Laboratory is a Florida LLC located in Palm Beach County, Florida. Id. ¶¶ 11-13.
The Laboratories are "affiliates" of Titan Healthcare, doing business as Ambrosia Treatment Center, located in Port St. Lucie, Florida. Id. ¶ 14. The Laboratories have no "parent corporation." See Pls.' Corporate Disclosure Statement.
Defendants are UnitedHealth Group, Inc. and United Healthcare Services, Inc. (collectively, "United"); and OptumInsight, Inc., and OptumHealth, Inc. (collectively, "Optum"). Located in Minnesota, Defendants administer and provide health insurance coverage. 1st Am. Comp. ¶¶ 16-21
There are 132 patients at issue in this case. Id. ¶ 2. Each of these patients is insured by Defendants or plans administered by them. Id. ¶¶ 21-22. From 2013 to 2014, each patient was treated by the Laboratories. Id. ¶ 24. The Laboratories are health care providers that provide medical services to substance abuse patients, specifically, drug screening urinalysis. Id. ¶¶ 3, 15.
Before receiving services from the Laboratories, the patients executed both a "Patient Assignment of Benefits and Financial Agreement" and a "Durable Power of Attorney." Id. ¶ 28.
The Assignment of Benefits reads as follows:
Id. ¶ 28.
The Durable Power of Attorney reads as follows:
Durable Power of Attorney, 1st Am. Comp., Ex. [ECF No. 26-3] (emphasis added).
And, further on:
Id. (emphasis added).
Before providing services to each patient, the Laboratories "verified the existence of coverage" with Defendants. 1st Am. Comp. ¶ 31. Defendants "confirmed coverage and that Plaintiffs Claims would be paid when timely submitted." Id.
The Laboratories filed claims with Defendants for the services provided to the patients. Id. ¶ 24. Some of the claims were paid, but others were delayed or denied. Id. ¶ 32. The delays were prolonged, and the reasons for denials shifted. Id. Sometimes when denying claims Defendants provided no more explanation than "misrepresentation of services." Id. ¶¶ 45-46.
On February 5, 2015, the Laboratories filed their First Amended Complaint, alleging seven counts against Defendants. Counts I-IV claim violations of the Employee Retirement Income Security Act of 1974 (ERISA). Count V and VI claim breach of contract and breach of implied contract. Count VII claims promissory estoppel. They seek $2,000,000 in unpaid claims. Id. ¶ 28.
The Employee Retirement Income Security Act of 1974 (ERISA), 29 U.S.C. ch. 18, regulates employer health insurance plans. ERISA provides beneficiaries a statutory cause of action to enforce their health insurance plan.
The Laboratories claim that Defendant violated ERISA by denying, and failing to provide the criteria used in denying their claims (Count I), by failing to provide full and a fair review of their denied claims (Count II), by breaching their fiduciary duties (Count III), and by failing to provide requested plan documents (Count IV).
Because neither the Assignment of Benefits nor the Power of Attorney provide the Laboratories standing to bring their ERISA claims, Counts I-IV will be dismissed with prejudice.
First, the Assignment of Benefits does not confer standing upon the Laboratories. The Assignment assigns only Ambrosia Treatment Center the right to receive benefits. It does not assign this right to the Laboratories. Even if it did, the Assignment would confer but limited standing. As the Eleventh Circuit has held, an assignment that authorizes a provider to receive benefits on a patient's behalf "assigns only the right to receive benefits and not the right to assert claims for breach of fiduciary duty or civil penalties" under ERISA.
Nor does the Power of Attorney confer standing upon the Laboratories. As Judges Cohn, Marra, and Huck have held, "a power of attorney is insufficient to give a plaintiff standing to pursue an action in his or her own name."
Recognizing their defective pleading, the Laboratories attach to their Response an affidavit from Ambrosia Treatment Center's Manager, Jerry Haffey, Sr. Affidavit of Jerry Haffey, Response to Motion to Dismiss, Ex. A., [ECF No. 28-2]. The Haffey Affidavit, "delegates [to the Laboratories] the authority to bring suit against [the Defendants] for reimbursement for services performed and separately billed by the [the Laboratories]." The affidavit is signed March 12, 2015. For at least two reasons the Haffey Affidavit is insufficient to confer standing upon the Laboratories.
First, Ambrosia Treatment Center cannot delegate its power of attorney. Ambrosia's authority to bring claims was authorized by the Power of Attorney that was executed by the patients. Although the Power of Attorney authorizes Ambrosia Treatment Center to delegate power to a third-party, Florida law forbids it. In Florida, a person assigned power of attorney is an agent and, "[n]otwithstanding the provision in the power of attorney, an agent who has accepted appointment . . . may not delegate authority to a third person" except for investment or government functions.
Second, "Article III standing must be determined as of the time at which the plaintiff's complaint is filed."
Because the Laboratories lack standing to bring their ERISA claims, Counts I-IV will be dismissed with prejudice.
In Count V, the Laboratories allege that United breached their insurance contracts with the patients "by failing to promptly pay, deny or contest the claims submitted by the Laboratories." 1st Am. Comp. ¶ 93. As a health care provider, the Laboratories have standing to sue as a third-party beneficiary to the contracts.
Nonetheless, the Laboratories have not alleged how United's breach harmed the Laboratories. To state a claim for breach of contract, the Laboratories must allege "damages to the third party resulting from the breach."
In Count VI, the Laboratories allege that Defendants breached an "implied contract" between the Laboratories and Defendants. The Laboratories do not clarify whether the contract is "implied in law" or "implied in fact."
If the contract is "implied in law," then Laboratories fail to state a claim as a matter of law. An element of an "implied in law" contract is that "the plaintiff has conferred a benefit on the defendant."
If the contract is "implied in fact," then the Laboratories have insufficiently pled their claim. "A contract implied in fact is one form of an enforceable contract; it is based on a tacit promise, one that is inferred in whole or in part from the parties' conduct, not solely from their words."
The Laboratories must allege that they and Defendants acted as if Defendants had assented to pay for the services it performed. This the Laboratories have not done. In fact, they have alleged the opposite. The Laboratories allege that they provided services to the patients for two years, but that Defendants made payments either inconsistently or not at all. This conduct shows that Defendants never assented to pay for the provided services. If anything, it shows they assented not to pay for them. Because the Court cannot imply a contract in fact or in law, Count VI will be dismissed without prejudice.
In Count VII, the Laboratories claim promissory estoppel, alleging that they reasonably relied upon Defendants' promise that the patients' claims were covered. "A promise which the promisor should reasonably expect to induce action or forbearance on the part of the promisee or a third person and which does induce such action or forbearance is binding if injustice can be avoided only by enforcement of the promise."
Affirmed by the Eleventh Circuit, Judge Gonzalez has held that an insurance company's confirmation of coverage is a representation that the patients are "covered for the type of treatment" proposed by the health care provider, not a definite promise to pay upon which reliance would be reasonable.
For the aforementioned reasons, it is hereby
1. Counts I-IV (ERISA) are
2. Count V-VIII (Breach of Contract) are
(1) The contract shall include the following provision:
Fla. Stat. § 627.6131(1).
Found. Health v. Westside EKG Associates, 944 So.2d 188, 195 (Fla. 2006); see also Weldon v. All Am. Life Ins. Co., 605 So.2d 911, 914 (Fla. 2d DCA 1992) (applying the general principle to determine the extent to which a chiropractor's services were covered under an insurance policy).